Group 1 - The core issue involves a false labeling incident related to Antarctic krill oil, where the company Beijing Tong Ren Tang Sichuan Health Pharmaceutical Co., Ltd. is incorrectly identified as a subsidiary of Beijing Tong Ren Tang Co., Ltd. [1][2] - Beijing Tong Ren Tang Co., Ltd. clarified that it is focused on the production and sales of pharmaceuticals, with no external third-party production involved [1][2] - As of December 17, the total market value of Beijing Tong Ren Tang Co., Ltd. is approximately 44.67 billion yuan [1] Group 2 - The Shanghai Consumer Protection Commission reported a potential fraud case involving a product labeled as "Beijing Tong Ren Tang 99% High Purity Antarctic Krill Oil," which claimed high phospholipid content but was found to have none [2] - The product in question is produced by Anhui Habao Pharmaceutical Co., Ltd. and distributed by Beijing Tong Ren Tang Sichuan Health Pharmaceutical Co., Ltd. [2]
同仁堂澄清南极磷虾油虚假标注涉事企业非其子公司